跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rexoscine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rexoscine
Approved
STANDARD
Rexoscine
Next Wave (India)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7c4a23fca7b0be71
Company
Next Wave (India)
Type
Standard
Approval Details
Approval Id
7c4a23fca7b0be71
Drug Approval Philippines Name
Rexoscine
Product Name
Rexoscine
Registration Number
DRP-11736
Brand Name
Rexoscine
Generic Name
Hyoscine-N-Butylbromide
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Next Wave (India)
Importer
Aarex Pharma Distributor
Distributor
Aarex Pharma Distributor
Issuance Date
25 April 2022
Expiry Date
25 April 2027
Pharmacologic Category
Antispasmodic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7c4a23fca7b0be71
Type
Standard
Back to Philippines FDA Approvals